Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022
Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022

TOKYO, Sep 12, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today results from a post hoc analysis of three randomized, pivotal, Phase 3 studies (EMBRACE trial/Study 305, Study 301 and Study304) evaluating the efficacy of eribulin mesylate (marketed as HALAVEN) versus other chemotherapies (Treatment of Physician’s Choice [TPC], capecitabine, and vinorelbine,... » read more

Eisai to Present Abstracts on Oncology Products And Pipeline at 44th Annual San Antonio Breast Cancer Symposium
Eisai to Present Abstracts on Oncology Products And Pipeline at 44th Annual San Antonio Breast Cancer Symposium

TOKYO, Dec 6, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that presentations on a series of abstracts highlighting updates on its in-house discovered eribulin mesylate (product name: Halaven, halichondrin class microtubule dynamics inhibitor, “eribulin”), MORAb-202, an antibody drug conjugate (ADC), and H3B-6545 (selective estrogen alpha receptor covalent antagonist), discovered by... » read more

New pill offers hope to patients with aggressive form of breast cancer

SINGAPORE – An orally consumed anti-cancer drug known as Bexarotene offers new hope to patients with triple-negative breast cancer (TNBC) – an aggressive form of breast cancer that appears more frequently among women below 40. This drug has been found to be able to tame highly aggressive and invasive breast cancer cells by converting them... » read more

Ask the Doc: Will eating soy increase my risk of breast cancer?
Ask the Doc: Will eating soy increase my risk of breast cancer?

What are some symptoms of gynaecologic cancers that women should not ignore? Most gynaecological cancers present with abnormal vaginal bleeding such as intermenstrual bleeding, bleeding after sex, or postmenopausal bleeding. Keep a lookout for vaginal discharge that may range from pink, watery and bloody to thick, brown and foul-smelling.  Additionally, symptoms can include pain in... » read more

Researchers use AI to identify the pH of cancer cells
Researchers use AI to identify the pH of cancer cells

SINGAPORE – National University of Singapore (NUS) researchers can now identify cancer cells by studying their acidity or pH levels using artificial intelligence technology. This technique could be potentially useful in detecting cancer cells in tissue samples, either obtained from tumour biopsies or liquid biopsies, which are blood tests. “As the number of cells in... » read more

HER2-positive breast cancers among the less common types
HER2-positive breast cancers among the less common types

Breast cancer is a disease that involves abnormal cell growth in the breast, which can spread to other parts of the body and cause health problems. It is the most common type of cancer in women internationally. In Singapore, breast cancer accounts for almost 30 per cent of cancers in women. Breast cancers can have... » read more

In sickness and in health, I take thee
In sickness and in health, I take thee

The hospital is no conventional location for wedding shoots, but it is a place that bears great significance for Ms Artika Raemi, 26, and Mr Aziz Abdullah, 28. The chemotherapy bay at the National University Cancer Institute, Singapore, was where Mr Aziz supported his fiancee through her breast cancer journey. Ms Artika, who is a... » read more